Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris

Regulatory Peptides

Volumn 175, Issue 1-3, 2012, Pages 7-10

  de Bold, Mercedes Kuroski ^a   Sheffield, William P ^b   Martinuk, Amy ^a   Bhakta, Varsha ^b   Eltringham Smith, Louise ^b   de Bold, Adolfo J ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Analogue; Atrial natriuretic factor; Congestive heart failure; Half life; Human serum albumin; Hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; CARDIOVASCULAR AGENT; CYCLIC GMP; HUMAN SERUM ALBUMIN ATRIAL NATRIURETIC FACTOR; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG HALF LIFE; FUNGUS CULTURE; GENETIC RECOMBINATION; IN VITRO STUDY; IN VIVO STUDY; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE;

AMINO ACID SEQUENCE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CYCLIC GMP; HALF-LIFE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PICHIA; RECOMBINANT FUSION PROTEINS; SERUM ALBUMIN;

MUS; PICHIA PASTORIS;

EID: 84858336635     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.01.005     Document Type: Article

References (15)

1. McGrath M.F., de Bold M.L., de Bold A.J. The endocrine function of the heart. Trends Endocrinol Metab 2005, 16:469-477.
2. Hata N., Seino Y., Tsutamoto T., Hiramitsu S., Kaneko N., Yoshikawa T., Yokoyama H., Tanaka K., Mizuno K., Nejima J., Kinoshita M. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study. Circ J 2008, 72:1787-1793.
3. Nomura F., Kurobe N., Mori Y., Hikita A., Kawai M., Suwa M., Okutani Y. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study. Circ J 2008, 72:1777-1786.
4. Schmidt S.R. Fusion-proteins as biopharmaceuticals-applications and challenges. Curr Opin Drug Discov Devel 2009, 12:284-295.
5. Sheffield W.P., Mamdani A., Hortelano G., Gataiance S., Eltringham-Smith L., Begbie M.E., Leyva R.A., Liaw P.S., Ofosu F.A. Effects of genetic fusion of factor IX to albumin on in vivo clearance in mice and rabbits. Br J Haematol 2004, 126:565-573.
6. Sheffield W.P., Smith I.J., Syed S., Bhakta V. Prolonged in vivo anticoagulant activity of a hirudin-albumin fusion protein secreted from Pichia pastoris. Blood Coagul Fibrinolysis 2001, 12:433-443.
7. Flynn T.G., de Bold M.L., de Bold A.J. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 1983, 117:859-865.
8. Flynn T.G., Davies P.L., Kennedy B.P., de Bold M.L., de Bold A.J. Alignment of rat cardionatrin sequences with the preprocardionatrin sequence from complementary DNA. Science 1985, 228:323-325.
9. Sarda I.R., de Bold A.J. A study on the factors affecting the radioimmunoassay of cardionatrin. Biologically active atrial peptides 1987, 213-215. Raven Press, New York. B.M. Brenner, J.H. Laragh (Eds.).
10. Huang Y.S., Chen Z., Yang Z.Y., Wang T.Y., Zhou L., Wu J.B., Zhou L.F. Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-alpha2b fusion protein expressed in Pichia pastoris. Eur J Pharm Biopharm 2007, 67:301-308.
11. Marques J.A., George J.K., Smith I.J., Bhakta V., Sheffield W.P. A barbourin-albumin fusion protein that is slowly cleared in vivo retains the ability to inhibit platelet aggregation in vitro. Thromb Haemost 2001, 86:902-908.
12. Schafer F., Schafer A., Steinert K. A highly specific system for efficient enzymatic removal of tags from recombinant proteins. J Biomol Tech 2002, 13:158-171.
13. Chen H.H., Martin F.L., Gibbons R.J., Schirger J.A., Wright R.S., Schears R.M., Redfield M.M., Simari R.D., Lerman A., Cataliotti A., Burnett J.C. Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study. Heart 2009, 95:1315-1319.
14. Lee C.Y., Burnett J.C. Natriuretic peptides and therapeutic applications. Heart Fail Rev 2007, 12:131-142.
15. Korinek J., Boerrigter G., Mohammed S.F., Burnett J.C. Insights into natriuretic peptides in heart failure: an update. Curr Heart Fail Rep 2008, 5:97-104.